Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$261K Sell
1,079
-2,630
-71% -$604K 0.18% 78
2021
Q4
$834K Sell
3,709
-89
-2% -$18.8K 0.1% 91
2021
Q3
$808K Sell
3,798
-166
-4% -$38.2K 0.1% 87
2021
Q2
$966K Buy
3,964
+204
+5% +$50.2K 0.12% 78
2021
Q1
$935K Sell
3,760
-523
-12% -$125K 0.12% 71
2020
Q4
$985K Sell
4,283
-853
-17% -$197K 0.13% 76
2020
Q3
$1.3M Sell
5,136
-1,074
-17% -$266K 0.16% 70
2020
Q2
$1.47M Sell
6,210
-1,149
-16% -$262K 0.2% 77
2020
Q1
$1.49M Buy
+7,359
New +$1.61M 0.24% 75

Other funds holding AMGN

Capital One Financial's AMGN Position: Q1 2022 in Review

Capital One Financial reduced its Amgen (AMGN) stake by 71% in Q1 2022, selling an estimated $604K and leaving 1,079 shares worth $261K. The position accounts for 0.18% of the portfolio, ranked #78.

Capital One Financial first reported a position in AMGN in Q1 2020 and has held it in 9 quarters since. The position peaked at $1.49M in Q1 2020. 2,336 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Capital One Financial held 1,079 shares of Amgen worth $261K as of Q1 2022.
  • Capital One Financial sold 2,630 Amgen shares in Q1 2022, an estimated $604K.
  • Amgen made up 0.18% of Capital One Financial's portfolio in Q1 2022, its #78 holding.
  • Capital One Financial first reported a position in Amgen in Q1 2020 and has held it in 9 quarters since.
  • Capital One Financial's Amgen position peaked at $1.49M in Q1 2020.
  • 2,336 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.